Veterinary Assistive Reproduction Technology Market Report 2025

This veterinary assistive reproduction technology market report delivers an in-depth analysis of the market’s key characteristics, including size, growth potential, and segmentation. It provides a detailed breakdown of the market across major regions and leading countries, highlighting historical data and future growth projections. The report also examines the competitive landscape, market share insights, emerging trends, and strategic developments shaping the market.

The veterinary assistive reproduction technology market size has grown strongly in recent years. It will grow from $3.36 billion in 2024 to $3.63 billion in 2025 at a compound annual growth rate (CAGR) of 7.9%. The growth in the historic period can be attributed to the desire to preserve and propagate valuable genetic traits, increasing demand for animal protein, increasing adoption across various animal species, and increased focus on animal health and welfare.

The veterinary assistive reproduction technology market size is expected to see strong growth in the next few years. It will grow to $4.88 billion in 2029 at a compound annual growth rate (CAGR) of 7.7%. The growth in the forecast period can be attributed to rising demand for high-value livestock and pets, a high population of livestock, supportive initiatives, growing investment in animal healthcare, and increasing pet ownership. Major trends in the forecast period include advancements in veterinary medicine, advancements in animal reproduction technology, integration of artificial insemination (AI), and enhanced breeding programs.

The veterinary assistive reproduction technology (VART) market is projected to grow due to the rising demand for livestock. This increased demand is driven by consumers' expectations for better taste and nutritional value, along with advancements in breeding technologies that create animals with desirable traits. VART enhances livestock breeding efficiency by supporting embryo fertilization and development, which boosts genetic improvement and productivity. For example, as reported by the Agriculture and Horticulture Development Board in August 2024, the number of female cattle over 24 months increased by 5,000 from the previous year, reaching a total of 235,000 as of December 2023. This trend underscores the growing demand for livestock and its impact on the VART market.

Key players in the VART market are focusing on innovation to improve reproductive efficiency and overall livestock health. This includes the development of advanced chelated minerals designed for dairy animals' reproductive health. These dietary supplements aim to enhance fertility and reproductive performance in dairy cattle. For instance, in July 2023, Rodec Pharma Limited, an India-based veterinary medicine manufacturer, launched CMIN H8. This advanced chelated mineral feed is specifically formulated to address common reproductive issues in the dairy industry, such as infertility, by improving the bioavailability of essential nutrients and supporting optimal reproductive health.

In March 2024, Calibre Scientific, a US-based life sciences company, acquired Microm UK for an undisclosed amount. This acquisition is intended to expand Calibre Scientific’s portfolio in assisted reproductive technologies, strengthen its commitment to reproductive health, and broaden its customer base in key markets. Microm UK, a UK-based provider of assisted reproductive technology, will complement Calibre Scientific's existing ART instruments with additional consumable products.

Major companies operating in the veterinary assistive reproduction technology market are Zoetis Inc., Merck Animal Health, IDEXX Laboratories Inc., Neogen Corporation, Genus plc, ABS Global Inc., Cryoport Inc., Minitube International Inc., Semex Alliance, Select Sires Inc., Cogent Breeding Ltd., Trans Ova Genetics LLC, Viking Genetics, Vytelle Inc., Agtech Inc., IMV Technologies, MOFA Global Inc., Emlab Genetics, Avantea Srl, Alta Genetics Inc., Aberekin S.L.

North America was the largest region in the veterinary assistive reproduction technology market in 2024. The regions covered in the veterinary assistive reproduction technology market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the veterinary assistive reproduction technology market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Veterinary assistive reproduction technology encompasses a range of advanced techniques and tools designed to enhance reproductive success in animals. These methods include artificial insemination, embryo transfer, and in vitro fertilization, all aimed at improving breeding efficiency, managing genetics, and increasing reproductive success across various animal species.

The primary categories of veterinary assistive reproduction technology include services, semen, instruments, and kits and consumables. The services involve procedures such as artificial insemination, embryo transfer, and in vitro fertilization, applied to animals such as cattle, pigs, sheep, goats, horses, and others. These services are distributed through both private and public channels. The technology supports various end users, including veterinary clinics and hospitals, animal breeding centers, research institutions, and universities.

The veterinary assistive reproduction technology market research report is one of a series of new reports that provides veterinary assistive reproduction technology market statistics, including veterinary assistive reproduction technology industry global market size, regional shares, competitors with a veterinary assistive reproduction technology market share, detailed veterinary assistive reproduction technology market segments, market trends and opportunities, and any further data you may need to thrive in the veterinary assistive reproduction technology industry. This veterinary assistive reproduction technology market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The veterinary assistive reproduction technology market includes revenues earned by entities by providing services such as semen cryopreservation, estrus synchronization, ovum pick-up (OPU), cloning, genetic preservation, and animal breeding. The market value includes the value of related goods sold by the service provider or included within the service offering. The veterinary assistive reproduction technology market also consists of sales of embryo transfer kits, semen collection systems, cryopreservation equipment, and diagnostic tools. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 3-5 business days.